FOX CHRISTINE (EVP, U.S. Commercial) sold 9.6% of their position (6.18K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $97.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2025ACC: 0000950170-25-034687
Officer· EVP, U.S. Commercial
Since Mar 2026
-6.18K
Net shares
Net seller
$97.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
20.46K acquired · 26.64K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+20.46K
Price / share
—
Trade value
—
% of position
46.4%
3/4/2025
44.10K→64.56K
Ordinary Shares
Direct
Shares
−4.03K
Price / share
$15.73
Trade value
$63.47K
% of position
6.2%
3/4/2025
64.56K→60.53K
Ordinary Shares
Direct
Shares
−2.15K
Price / share
$15.91
Trade value
$34.17K
% of position
3.5%
3/5/2025
60.53K→58.38K
Total
Net shares
+14.28K
Net value
-$97.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/4/2025 | M · Option Exercise | +20.46K | — | — | 46.4% | 44.10K | 64.56K |
| Ordinary Shares Direct | 3/4/2025 | S · Sale | −4.03K | $15.73 | $63.47K | 6.2% | 64.56K | 60.53K |
| Ordinary Shares Direct | 3/5/2025 | S · Sale | −2.15K | $15.91 | $34.17K | 3.5% | 60.53K | 58.38K |
| Total | +14.28K | -$97.64K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
20.46K shares
Shares
−20.46K
Strike price
Held after
61.38K
Exercisable
—
3/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares20.46K shares | 3/4/2025 | M · Option Exercise | −20.46K | — | 61.38K |